■ INTRODUCTION
17 Biologics might represent the only efficient way to treat some 18 specific diseases but, in many cases, the solid-state form of these 19 entities cannot be easily used in a dosage form due to their 20 questionable physiochemical properties (e.g., stability). Bio-21 logics typically exist in the amorphous state with consequent 22 disadvantageous therapeutic and preformulation properties. A 23 possible contemporary solution to this crystallizability issue is 24 the preparation of crystal forms of these molecules using and 25 applying the concepts of crystal engineering and molecular 26 complexes.
1 Hydrophobic peptides can be considered as small 27 prototypes of biologics with a nontoxic, biocompatible, and 28 ecological profile. From a chemical and crystal engineering 29 point of view, their hydrophobic and hydrophilic moieties are 30 very attractive because of the possibility to generate both 31 hydrogen bonded and van der Waals interactions leading to 32 different types of crystal packing landscapes. 33 An innovative aspect presented in this work is the use of co-34 crystallization as an alternative method to overcome the 35 problematic removal of unwanted trifluoroacetic acid (TFA) 36 from a synthesized peptide. The presence of such chemical is a 37 common challenge when peptides are synthesized through solid 38 or solution phase peptide synthesis. For example, the final step 39 in the solid phase peptide synthesis (SPPS) 2 is represented by Crystal Growth & Design Article Crystal Growth & Design Crystal data and refinement parameters are presented in Table 1 . 180 Structure solutions were carried out by direct methods and refinement 181 with SHELXL 28 was finished using the ShelXle 29 software. All non-182 hydrogen atoms were found from electron density map and refined 183 with fixed bond distances and thermal parameter riding on the parent 184 atom. Highly disordered electron density inside the channel of LLhex 185 was processed using Platon Squeeze. Figure 9b ) is involved in a bifurcated 322 H···O − contact with the carboxy-terminal of a dipeptide.
323
Nanotube Structure. The crystal packing of LL:hex can be 324 included in the reported cases of nanotubes obtained using 325 hydrophobic dipeptides. 27 This structure crystallizes in P6 1 .
326
The dipeptides are connected into chains by strong bifurcated 
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Article DOI: 10.1021/acs.cgd.7b01516 Cryst. Growth Des. XXXX, XXX, XXX−XXX 338 crystallizes in P2 1 2 1 2 1 with four molecules per turn in the 339 helices. The L-Phe-L-Phe hexagonal structure described by 340 Gorbitz in the same paper (IFABEW) is highly similar to 341 LLhex ( Figure S8 ). The hydrophilic channel is around 10 Å in 342 diameter comprising 15% of the unit cell volume and it likely 343 contains methanol and water (SI for details).
344
■ CONCLUSION 345 The success in obtaining TFA-free multicomponent crystals 346 represents a proof of concept for the use of crystal engineering 347 as an alternative purification method for freshly synthesized 348 peptides. Further studies aiming to probe the kinetics and 349 thermodynamics behind the differential crystallization mecha-350 nisms are the next step. Such investigations will bring about the 351 control of the process and allow a combined purification and 352 crystallization of biologics in a single step, saving time and 353 material. 354 In the previously reported case of studies on the 355 crystallization of hydrophobic peptides, the impact of TFA 356 was not investigated since the dimers used for the experiments 357 were obtained commercially with a high grade of purity. 
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